Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CELEXT07 in Toenail Onychomycosis
NCT02644551Phase 2Unknown
- Sponsor
- 9305-9954 Quebec
- Start
- Nov 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CELEXT-07 in onychomycosis, sponsored by 9305-9954 Quebec. Status: unknown.
02
Drugs
CELEXT-07
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT02644551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644551.